Objective and Scope:
The client, an advisory firm based in the United States, aimed to support its client in managing Scope 3 emissions for two key product categories: health and wellness and medtech. It sought Benori’s support to:
- Build a model to quantify Scope 3 emissions at a product level by analyzing its components at a molecular level and aligning them to established emission factors
- Identify decarbonization opportunities for Scope 3 emissions in the health and wellness and medtech sectors, including case studies from industry leaders in these product categories
Approach:
Our approach was to analyze the products at the molecular and component level and find suitable proxies for materials lacking documented emission factors. Using free and paid databases, industry reports, articles, company websites, and blogs, we identified the components/molecules and their emission factors, additionally gathered information on key decarbonization levers from multiple sources, and developed case studies from key businesses in the industry.
Impact:
The research helped the client in:
- Understanding the molecular composition of products and their carbon emissions, to track Scope 3 emissions
- Identifying decarbonization strategies and examples to understand industry leaders' initiatives and long-term goals for reducing carbon footprints over the upcoming years
